Fondaio Weight Loss Drug Prices in Qatar
The Ministry of Public Health in Qatar has announced the registration of the medication "Voundayo" (Orforglipron), a new oral treatment for weight loss and weight management, developed by Eli Lilly. The drug is available in the Qatari market in three dosages, with prices ranging from 849.50 to 1,225.25 Qatari Riyals. It is dispensed by prescription and under the supervision of a specialist in obesity treatment. The medication is used alongside a low-calorie diet and regular physical activity, targeting adults who are obese or overweight with related health conditions, such as type 2 diabetes or hypertension. The active ingredient, "Orforglipron," helps regulate appetite through its effects on the brain and slows gastric emptying to increase feelings of satiety. The drug is taken once daily, starting with a low dose that gradually increases. It is important to note that the most common side effects are related to the digestive system, including nausea, constipation, and vomiting, and require medical follow-up—particularly in cases with contraindications such as pregnancy or a history of thyroid cancer. This registration aims to expand the therapeutic options for combating obesity in Qatar, emphasizing the importance of medical supervision to avoid potential complications.
Notice: This Is an AI-Generated Summary
Comments (0)